As we wrap up this discussion on sepsis with a focus on the enlightening recent clinical trials on EGDT, I’d like to thank the authors and experts for participating, and the NEJM Group and Medstro for organizing this discussion. I’d also like to invite the authors and experts to offer any closing remarks about any topic you deem important (perhaps one that wasn’t covered adequately).
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this challenge
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.